GMP Certified mRNA Manufacturing Site, BioNTech, Marburg, Germany
Next-gen immunotherapy company BioNTech announced this month the completion of a share purchase agreement with Swiss pharma giant Novartis AG,
Read more
RNA
Moderna’s mRNA COVID-19 vaccine generates antibodies in Phase I trial
Moderna’s COVID-19 vaccine candidate generated antibodies in all 45 patients studied in its early stage human trial, the U.S biotech
Read more
Tesla to help COVID-19 vaccine developer CureVac with molecule printers
Tesla Inc is engineering mobile molecule printers to help produce the future COVID-19 vaccine developed by CureVac in Germany, the
Read more
Moderna’s mRNA COVID-19 vaccine (mRNA-1273) fast-tracked by FDA
Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced on May 12, that
Read more
Moderna and Lonza partner up to manufacture COVID-19 vaccine
Moderna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more
Intermediate analysis of Moderna’s Phase I Zika Vaccine (mRNA-1893)
The first intermediate analysis of the Phase I Zika vaccine candidate sample (mRNA-1893) reveals that the dosage levels of 10
Read more
Skin cancer drug trial boosts CK Life Sciences stock by 240%
CK Life Sciences stock jumps 240% as skin cancer drug trial looks promising. Seviprotimut-L could serve as a significant innovation in the vaccine-based treatment of melanoma.
Read more